Game-based Telehealth Therapeutic Intervention in First Onset Psychosis

Sponsor
Stanford University (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04799717
Collaborator
(none)
20
1
18.9
1.1

Study Details

Study Description

Brief Summary

The goal is to provide combination of 2 hours of weekly game based telehealth therapeutic intervention along with CBT-P for children identified with first onset psychosis or to be clinically high risk for psychosis thus widening therapeutic services offered. Target outcome measures are improvement in clinical symptoms, treatment engagement, and reduced hospitalization rates.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Gaming session

Detailed Description

Patients with first onset psychosis or clinical high risk for psychosis often have significant functional decline affecting social, academic, and daily living skills. Given their constellation of new onset psychotic symptoms of paranoia, delusions, hallucinations, and additionally co-morbid anxiety, or depression, patients most often present with school refusal, social withdrawal, aggression, poor self-care, and treatment noncompliance. This leads to decline in quality of life for both patients and families, along with increased sick days, recurrent hospitalizations, residential treatment center admissions which aren't always covered by insurance. Families are often left with very little to intervene and they carry the long-term disease burden of a significant diagnosis in addition to pocketing out of network costs for therapy. Further clinical programs like intensive outpatient programs or partial hospitalization programs often reject candidates with psychosis due to severity of symptoms and low levels of engagement when compared to their counterparts. County services offering in home therapeutic support services like rehabilitation, family therapy, peer support and wrap around services do not apply to insured patients thus causing huge gap in need for services. Early treatment with therapy and medications in first onset psychosis is very valuable as repeatedly shown clinically and in research.

Method: 10 patients in the 10-18 year age group meeting criteria for clinical high risk psychosis and schizophrenia spectrum disorders will be selected using DSM 5 criteria. Patients will be seen twice weekly for 15 weeks. They will be offered weekly individual telehealth therapy using game-based approach for first half of their visit to encourage engagement with therapist. Safe online videogames of their choice will be chosen, allowing usage of computer or electronics during session as needed to serve treatment purposes. The other half of the visit will focus on psychoeducation and utilizing CBT-P components targeting symptoms of psychosis. Patients will be assessed once a month clinically by treating psychiatrist in INSPIRE clinic to track symptom reduction, treatment engagement and hospitalization. Outcome measures will be tracked each month and data compiled between 4/2021-6/2021.

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Game-based Telehealth Therapeutic Intervention in First Onset Psychosis
Actual Study Start Date :
Sep 2, 2021
Anticipated Primary Completion Date :
Jan 1, 2023
Anticipated Study Completion Date :
Apr 1, 2023

Outcome Measures

Primary Outcome Measures

  1. Number of Participants with a Hospitalization [The 15 week participation period]

    Review patient's medical record for number of hospitalizations due to psychotic disorder

  2. Patient Session Engagement [The 15 week participation period.]

    Measure client engagement in treatment by providing a post-session survey. The survey has four questions to solicit client feedback on the therapy session. The clients will answer on a scale of 1-10 with 1 being the lowest and 10 being the highest score. Add all four numbers together to obtain the total score.

  3. Brief Psychiatric Rating Scale Scores [The 15 week participation period.]

    Perform the Brief Psychiatric Rating Scale (BPRS). The BPRS is a 21 questionaire of present of mental health symptoms wtih each question scored on a Likert scale of 1-7. A score of 01reflects that a particular question was not assessed and a score of 7 is highest severity of the symptom listed in each individual question. A total score is not calculated.

Eligibility Criteria

Criteria

Ages Eligible for Study:
10 Years to 18 Years
Sexes Eligible for Study:
All
Inclusion criteria is one of the following diagnoses:
  • Clinical Diagnosis of Schizophrenia spectrum disorders

  • Major Depressive Disorder with Psychotic Features

  • Schizophrenia,

  • Attenuated psychosis syndrome,

  • Brief psychotic disorder,

  • Schizoaffective Disorder,

  • Schizophreniform disorder

  • Unspecified psychotic disorder

  • Clinical high risk for psychosis

Exclusion Criteria:

-Clinical Diagnosis of Intellectual Disability

Contacts and Locations

Locations

Site City State Country Postal Code
1 Stanford Universtiy Palo Alto California United States 94305

Sponsors and Collaborators

  • Stanford University

Investigators

  • Principal Investigator: Janani Venugopalakrishnan, MD MPH, Stanford University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Janai Venugopalakrishnan, Clinical Assistant Professor, Stanford University
ClinicalTrials.gov Identifier:
NCT04799717
Other Study ID Numbers:
  • 59698
First Posted:
Mar 16, 2021
Last Update Posted:
Jun 3, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Janai Venugopalakrishnan, Clinical Assistant Professor, Stanford University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 3, 2022